IL1B and cancer: However, the administration of Z-360 (100 mg/kg) once a day from day 7 to 14 after transplantation significantly reduced the levels of IL-1β protein in the cancer-inoculated region by 54.3% compared to the vehicle-treated group in cancer-induced pain mice (p <0.05) (Figure 4B).